Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferrara

Showing results (511-520 of 566) with videos related to

Pageof 57
Sort By:
Bone Marrow Transplantation|September 2, 2021
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkersStelios Kasikis, Janna Baez, Isha Gandhi, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
The reparative immunologic consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Gut|February 17, 2025
Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantationErin Gatza, Thomas Braun, John E Levine, et al.
Blood|October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseJames L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|February 29, 2012
Atopic dermatitis (AD) management in an Italian pediatric clinicG Ruggiero, C Gelmetti, M C Adamo, et al.
Blood|October 4, 2008
A biomarker panel for acute graft-versus-host diseaseSophie Paczesny, Oleg I Krijanovski, Thomas M Braun, et al.
Neuroimage. Clinical|January 23, 2015
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) studyM Pagani, F De Carli, S Morbelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-diseaseJohn M Magenau, Xuemei Qin, Isao Tawara, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2019
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort studySara Modica, David Redi, Roberta Gagliardini, et al.
Pageof 57

Showing results (511-520 of 566) with videos related to

Sort By:
Pageof 57
Bone Marrow Transplantation|September 2, 2021
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkersStelios Kasikis, Janna Baez, Isha Gandhi, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
The reparative immunologic consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Gut|February 17, 2025
Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantationErin Gatza, Thomas Braun, John E Levine, et al.
Blood|October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseJames L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|February 29, 2012
Atopic dermatitis (AD) management in an Italian pediatric clinicG Ruggiero, C Gelmetti, M C Adamo, et al.
Blood|October 4, 2008
A biomarker panel for acute graft-versus-host diseaseSophie Paczesny, Oleg I Krijanovski, Thomas M Braun, et al.
Neuroimage. Clinical|January 23, 2015
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) studyM Pagani, F De Carli, S Morbelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-diseaseJohn M Magenau, Xuemei Qin, Isao Tawara, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2019
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort studySara Modica, David Redi, Roberta Gagliardini, et al.
Pageof 57